In this study, we aimed to discussclinicopathological features and treatment approach in 5 women with MBC.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Metaplastic breast carcinoma (MBC) is a general term defining a heterogeneous group that includes biphasic lesions, withboth malignant epithelial and mesenchymal tissue components.
📊
Key Findings & Data:Most common distant metastasis areas include lungs and the bone.Although the treatment generally relies on the same principles applied in invasive ductal carcinoma, a more aggressivetreatment should be employed in at-risk groups due to higher rates of local recurrence.
💡
Conclusion & Impact:In this study, we aimed to discussclinicopathological features and treatment approach in 5 women with MBC.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Metaplastic breast carcinoma (MBC) is a general term defining a heterogeneous group that includes biphasic lesions, withboth malignant epithelial and mesenchymal tissue components. Although its clinical findings are similar to those present ininvasive ductal carcinoma, it rarely presents with the findings of inflammatory breast cancer. It is generally seen in the fifthdecade. MBC spreads via lymph and blood circulation. Most common distant metastasis areas include lungs and the bone.Although the treatment generally relies on the same principles applied in invasive ductal carcinoma, a more aggressivetreatment should be employed in at-risk groups due to higher rates of local recurrence. In this study, we aimed to discussclinicopathological features and treatment approach in 5 women with MBC.
🔖
Cite This Article
SEZGİN, G., HACIYANLI, M., ACAR, T., ACAR, N., GÖKOVA, M. B., KÜÇÜKZEYBEK, B. B. (2022). Treatment choice in metaplastic breast cancer: A report of 5 cases. İstanbul Kuzey Klinikleri, Cilt: 5 - Sayı: 4, 365–369. https://ajindex.com/articles/551528
Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ. WHO classification of tumors of the breast World Health Organization classification of tumours. 4th. Lyon: IARC Press; 2012. p. 48–52
Breast Cancer from Molecular Point of View: Pathogenesis and Biomarkers. Available at: https://www.intechopen.com/books/breast-cancer- focusing-tumor-microenvironment-stem-cells-and-metastasis/ breast-cancer-from-molecular-point-of-view-pathogenesis-andbiomarkers. Accessed July 5, 2018
DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin 2014;64:52–62
Luini A, Aguilar M, Gatti G, Fasani R, Botteri E, Brito JA, et al. Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat 2007;101:349–53
Yang WT, Hennessy B, Broglio K, Mills C, Sneige N, Davis WG, et al. Imaging differences in metaplastic and invasive ductal carcinomas of the breast. AJR Am J Roentgenol 2007;189:1288–93
Lai HW, Tseng LM, Chang TW, Kuo YL, Hsieh CM, Chen ST, et al. The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma. Breast 2013;22:968–73
Song Y, Liu X, Zhang G, Song H, Ren Y, He X, et al. Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators. World J Surg Oncol 2013;11:129
Leddy R, Irshad A, Rumboldt T, Cluver A, Campbell A, Ackerman S. Review of metaplastic carcinoma of the breast: imaging findings and pathologic features. J Clin Imaging Sci 2012;2:21
Choi BB, Shu KS. Metaplastic carcinoma of the breast: multimodality imaging and histopathologic assessment. Acta Radiol 2012;53:5–11
Kuo SH, Chen CL, Huang CS, Cheng AL. Metaplastic carcinoma of the breast: analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer. Anticancer Res 2000;20:2219–22
Tse GM, Tan PH, Putti TC, Lui PC, Chaiwun B, Law BK. Metaplastic carcinoma of the breast: a clinicopathological review. J Clin Pathol 2006;59:1079–83
Park HS, Park S, Kim JH, Lee JH, Choi SY, Park BW, et al. Clinicopathologic features and outcomes of metaplastic breast carcinoma: comparison with invasive ductal carcinoma of the breast. Yonsei Med J 2010;51:864–9